OCGN logo

OCGNOcugen Inc

$1.30
$0.09
(6.57%)
Today
Closed $1.28
$0.02
(1.56%)
After Hours
Updated: 07:26 PM EDT
EarningsJul 30
Mkt Cap$463.77M
Vol5.28M
39

Bearish Sentiment

How do you feel about OCGN?

About

Ocugen, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies to cure eye diseases. Its product pipeline candidates include OCU400, OCU410, OCU200, and COVAXIN. The firm's modifier gene therapy platform is engaged in addressing retinal diseases, including retinitis pigmentosa, leber congenital amaurosis, and dry age-related macular degeneration. The company was founded by Shankar Musunuri and Uday B. Kompella in 2013 and is headquartered in Malvern, PA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
116

Frequently Asked Questions

What is Market Cap of Ocugen Inc?
What is the 52-week high for Ocugen Inc?
What is the 52-week low for Ocugen Inc?
What is Ocugen Inc stock price today?
What was Ocugen Inc stock price yesterday?
What is the PE ratio of Ocugen Inc?
What is the Price-to-Book ratio of Ocugen Inc?
What is the 50-day moving average of Ocugen Inc?
How many employees does Ocugen Inc have?